Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

EPHB1 wt Allele

Known as: EPHB1, Hek6, EPH Receptor B1 wt Allele 
Human EPHB1 wild-type allele is located within 3q21-q23 and is approximately 464 kb in length. This allele, which encodes ephrin type-B receptor 1… Expand
National Institutes of Health

Related topics

Related topics

11 relations
3q21-q23Axon GuidanceEphrin Receptor EphB1Ephrin Type-B Receptor 1, human
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Ligand-independent EphB1 signaling mediates TGF-β-activated CDH2 and promotes lung cancer cell invasion and migration
Purpose: The initial step of cancer metastasis is that cancer cells acquire the capability to migrate and invade. Eph receptors… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
2018
2018
Sumoylation of EphB1 Suppresses Neuroblastoma Tumorigenesis via Inhibiting PKCγ Activation
  • Qin Chen, R. Deng, +8 authors Jianxiu Yu
  • Cellular Physiology and Biochemistry
  • 2018
    • Corpus ID: 3975401
Background/Aims: An increasing number of studies have linked erythropoietin-producing hepatocellular carcinoma (Eph) family… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2017
2017
Spinal ephrinBs / EphBs signaling system mediating diabetic neuropathic pain in rats through the regulation of central sensitization by MAPKs
Objective: To observe the effect of spinal cord level echrinBs/EphBs signaling system relied on MAPKs to regulate diabetic… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 6
2014
2014
EphB1 and Ephrin-B, new potential biomarkers for squamous cell/adenosquamous carcinomas and adenocarcinomas of the gallbladder.
  • Yuan Yuan, Z. Yang, +7 authors Sen-lin Chen
  • Asian Pacific journal of cancer prevention…
  • 2014
    • Corpus ID: 23995636
Squamous cell/adenosquamous carcinoma (SC/ASC) of the gallbladder are rare tumors and there are few clinical reports in the… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
2013
2013
Involvement of EphB1 Receptors Signalling in Models of Inflammatory and Neuropathic Pain
EphB receptors tyrosine kinases and ephrinB ligands were first identified as guidance molecules involved in the establishment of… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
2013
2013
Ligand-dependent EphB1 signaling suppresses glioma invasion and correlates with patient survival.
BACKGROUND Extensive evidence implicates the Eph receptor family of tyrosine kinases and its ligand, ephrin, in glioma invasion… Expand
  • figure 1
  • figure 3
  • figure 4
  • figure 6
  • figure 7
Highly Cited
2008
Highly Cited
2008
Zic2 Regulates Retinal Ganglion Cell Axon Avoidance of ephrinB2 through Inducing Expression of the Guidance Receptor EphB1
The navigation of retinal axons to ipsilateral and contralateral targets in the brain depends on the decision to cross or avoid… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2007
Highly Cited
2007
EphB Receptors Regulate Stem/Progenitor Cell Proliferation, Migration, and Polarity during Hippocampal Neurogenesis
The adult brain maintains two regions of neurogenesis from which new neurons are born, migrate to their appropriate location, and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2007
2007
EphB1 null mice exhibit neuronal loss in substantia nigra pars reticulata and spontaneous locomotor hyperactivity
The molecular mechanisms that regulate basal ganglia development are largely unknown. Eph receptor tyrosine kinases are potential… Expand
Highly Cited
2007
Highly Cited
2007
Involvement of EphB1 Receptor/EphrinB2 Ligand in Neuropathic Pain
Study Design. We investigated involvement of EphB/ephrinB system in neuropathic pain. Objective. Using immunoblotting… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE